About Aeglea BioTherapeutics

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
biotechnology
Location
Location
Austin, Texas, US
Description
Information
Aeglea is a clinical-stage biotechnology company that engineers next-generation human enzymes with enhanced properties and novel activity to provide solutions for diseases with unmet medical need. Aeglea is developing pegzilarginase, its lead product candidate, for the treatment of Arginase 1 Deficiency which has received both Rare Pediatric Disease and Breakthrough Therapy Designation. Aeglea has two programs in IND-enabling studies for Homocystinuria and Cystinuria and an active discovery pipeline.

Aeglea BioTherapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Aeglea BioTherapeutics

What is Aeglea BioTherapeutics email format?

The widely used Aeglea BioTherapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Aeglea BioTherapeutics customer service number?

To contact Aeglea BioTherapeutics customer service number in your country click here to find.


Who is the CEO of Aeglea BioTherapeutics?

David G Lowe is the CEO of Aeglea BioTherapeutics. To contact David G Lowe email at [email protected]. Or you may call +1.5129422935


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more